123832 Agilent- Intent to Sole Source.doc
DOC document 28 KB Posted
- Attached to
- An Intent to Sole Source Quadriple Mass Spec
- Solicitation number
- FDA-ORA-2024-123832
About this file
This document is a Notice of Intent to Sole Source for a service contract to repair an Agilent Triple Quadrupole Mass Spectrometer System. The Food and Drug Administration (FDA) intends to award a sole-source contract to Agilent Technologies, the original equipment manufacturer, for this repair service, with an estimated value under $22,000. The justification is that Agilent is the sole-source provider for this system. The FDA is publishing this notice pursuant to FAR 5.203(a) and 6.302-1, which allows for sole-source contracting under certain circumstances. The FDA is providing this notice to determine if there are any interested parties that could also perform this service. Questions or comments must be submitted to the Contract Specialist within 7 days of the notice posting. This is not a request for quotes or proposals.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT TO SOLE SOURCE
Project Title: Agilent Technologies Inc Service Contract Announcement No: FDA-2024-123832 The Government hereby submits a notice of intent to award a sole source contract to AGILENT TECHNOLOGIES for Agilent Triple Quadrupole Mass Spectrometer System service repair total estimated value is less than 22K This sole source contracting action is a notice pursuant to FAR 5.203(a) for the requirement based on the application of FAR 6.302-1. This hereby constitutes a synopsis of this requirement.
This is an award under NAICS Code 334516. AGILENT TECHNOLOGIES is the sole-source service provider for Agilent Triple Quadrupole Mass Spectrometer System. The time has come to repair the system. A single service contract will ensure that the system can return to normal operations and will properly function for years to come.
The determination not to compete this proposed contract action solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice.
This is NOT a request for quotes or proposals.
Questions or comments to this Notice of Intent should be directed to Contract Specialist, Courtney Black, at Courtney.Black@fda.hhs.gov (via email only) and within 7 days of the notice of intent posting date. Please be advised no phone calls/voice mail messages regarding questions will be accepted and nor will they receive a response). Please indicate in the subject line of your email: Notice of Intent Questions Submission – FDA-2024-123832
File details come from the government source that posted it. Updated .